AML-397 Integrated Safety Analysis of Tagraxofusp, a CD123-Directed Targeted Therapy, in Patients With Hematologic Malignancies

Authors :: Naveen Pammaraju
Hagop Kantarjian
Kendra Sweet
Eunice S. Wang
Andrew A. Lane
Haris Ali
Anthony S. Stein
Abdulraheem Yacoub
David Rizzieri
Sumithira Vasu
Vikas Gupta
Sangmin Lee
Gary J. Schiller
James M. Foran
Minakshi S. Taparia
Todd L. Rosenblat
Roland B. Walter
Deborah Sieminski
Madhu Anant
Mrinal M. Patnaik
Tariq I. Mughal
Marina Konopleva
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S246-S247
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools